These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8956455)

  • 1. Is cancer dangerous to the immune system?
    Fuchs EJ; Matzinger P
    Semin Immunol; 1996 Oct; 8(5):271-80. PubMed ID: 8956455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How the immune system achieves self-nonself discrimination during adaptive immunity.
    Jiang H; Chess L
    Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumors derived from antigen presenting cells.
    Levitsky HI
    Semin Immunol; 1996 Oct; 8(5):281-7. PubMed ID: 8956456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune system--is it relevant to cancer development, progression and treatment?
    Prestwich RJ; Errington F; Hatfield P; Merrick AE; Ilett EJ; Selby PJ; Melcher AA
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):101-12. PubMed ID: 18037277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumors and the danger model.
    Kowalczyk DW
    Acta Biochim Pol; 2002; 49(2):295-302. PubMed ID: 12362970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?
    Salih HR; Nüssler V
    Eur J Med Res; 2001 Aug; 6(8):323-32. PubMed ID: 11549514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fresh look at tumor immunosurveillance and immunotherapy.
    Smyth MJ; Godfrey DI; Trapani JA
    Nat Immunol; 2001 Apr; 2(4):293-9. PubMed ID: 11276199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell death recognition model for the immune system.
    Sun E
    Med Hypotheses; 2008; 70(3):585-96. PubMed ID: 17681705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-host immune interactions and dendritic cell dysfunction.
    Yang L; Carbone DP
    Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The danger model: a renewed sense of self.
    Matzinger P
    Science; 2002 Apr; 296(5566):301-5. PubMed ID: 11951032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'kiss of death' by dendritic cells to cancer cells.
    Chan CW; Housseau F
    Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of immune systems from self/not self to danger to artificial immune systems (AIS).
    Cooper EL
    Phys Life Rev; 2010 Mar; 7(1):55-78. PubMed ID: 20374928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The flip side of immune surveillance: immune dependency.
    Prehn RT; Prehn LM
    Immunol Rev; 2008 Apr; 222():341-56. PubMed ID: 18364013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new hypothesis on the immune surveillance of tumors].
    Jansa P
    Acta Univ Palacki Olomuc Fac Med; 1984; 107():139-42. PubMed ID: 6242634
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of the self/non-self-survey in the defense against cancer: potential for chemoprevention?
    Sharma RA; Browning MJ
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):5-22. PubMed ID: 15978831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
    Corthay A; Lundin KU; Lorvik KB; Hofgaard PO; Bogen B
    Cancer Res; 2009 Jul; 69(14):5901-7. PubMed ID: 19567679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From cancer immunosurveillance to cancer immunotherapy.
    Stagg J; Johnstone RW; Smyth MJ
    Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing immune responses for cancer therapy.
    Xue SA; Stauss HJ
    Cell Mol Immunol; 2007 Jun; 4(3):173-84. PubMed ID: 17601371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells in immune surveillance and treatment of cancer.
    Yamaguchi T; Sakaguchi S
    Semin Cancer Biol; 2006 Apr; 16(2):115-23. PubMed ID: 16376102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.